Clinical Trial Update: FocaL Mass Drug Administration for Vivax Malaria Elimination [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating focal mass drug administration to eliminate Plasmodium vivax malaria; recruitment is ongoing, sponsored by the University of C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Snippet

Sponsor: University of California, San Francisco | Conditions: Plasmodium Vivax Malaria, Malaria | Phase 3 | Status: RECRUITING